EU Regulator: AstraZeneca Vaccine Effective, Blood Clots May Be A Rare Side Effect
The European Medicines Agency said Wednesday that blood clots should be listed as possible but rare side effect of the AstraZeneca COVID-19 vaccine, stressing the shot's benefits outweigh the risks.
The European Medicines Agency said Wednesday that blood clots should be listed as possible but rare side effect of the AstraZeneca COVID-19 vaccine, stressing the shot's benefits outweigh the risks.
You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002
No comments:
Post a Comment